Tobacco and cannabis poly-substance and poly-product use trajectories across adolescence and young adulthood.

Authors:
Lanza HI; Bello MS; Cho J; Barrington-Trimis JL; McConnell R and 3 more

Journal:
Prev Med

Publication Year: 2021

DOI:
10.1016/j.ypmed.2021.106545

PMCID:
PMC8851564

PMID:
33812854

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Prev Med

Abbreviation: Prev Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Learning from community-based HIV prevention to inform control and mitigation of the COVID-19 pande…
Abrams JA; Rutledge J; Opara I. (2023) - Transparency Score: 3/6
Political variations in pandemic lifestyles and COVID-19 vaccination by age cohort in the United St…
Dowd-Arrow B; Burdette AM; Smith A. (2023) - Transparency Score: 3/6
Racial differences in COVID-19 severity associated with history of substance use disorders and over…
Allen B; Basaraba C; Corbeil T and 8 more (2023) - Transparency Score: 3/6
The effectiveness of financial incentives for COVID-19 vaccination: A systematic review.
Khazanov GK; Stewart R; Pieri MF and 5 more (2023) - Transparency Score: 4/6
Assessing the effect of COVID-19 stay-at -home orders on firearm injury in Maryland.
Frost E; Garg A; Nasr I and 1 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest: The authors have no conflicts of interest relevant to this article to disclose."

Evidence found in paper:

"Funding source This project was supported in part by Tobacco Centers of Regulatory Science (TCORS) award U54CA180905 from the National Cancer Institute (NCI) and the US Food and Drug Administration (FDA), award number R01CA229617 from the NCI, award number 27-IR-0034 from the California Tobacco-Related Disease Research Program (TRDRP), and award number K01DA042950 and K24DA048160 from the National Institute on Drug Abuse (NIDA)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025